Vaidyalingam N
Department of Psychiatry, Govt. Mental Hospital, Madras.
J Postgrad Med. 1990 Apr;36(2):100-3.
Thirty chronic schizophrenic patients completed 12 week treatment with a single weekly dose of 20 mg penfluridol, a new long acting oral neuroleptic. The patients were evaluated by using modified rating scale. Significant reduction in scores was demonstrated in 15 out of 26 symptom variables. Few side effects were reported which were easily controlled by conventional antiparkinson agents. Laboratory investigations remained within normal limits.
30例慢性精神分裂症患者接受了为期12周的治疗，每周单次服用20毫克五氟利多，这是一种新型长效口服抗精神病药物。采用改良评分量表对患者进行评估。26个症状变量中有15个显示分数显著降低。报告的副作用很少，常规抗帕金森药物很容易控制。实验室检查结果均在正常范围内。
